Amlodipine And Olmesartan Medoxomil
Amlodipine Besylate + Olmesartan Medoxomil
8 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 22 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Amlodipine Besylate + Olmesartan Medoxomil
Average across 22 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | generic | 16 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 12 | SUPPLYING |
| ScieGen Pharmaceuticals Inc | unknown | 12 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 6 | SUPPLYING |
| AvKARE | relabeler | 4 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 4 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 4 | SUPPLYING |
| A-S Medication Solutions | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
cGMP deviations — Recalling firm: Macleods Pharma Usa Inc — USA Nationwide
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach). — Recalling firm: Aurobindo Pharma USA Inc. — U.S.A. Nationwide